Key Takeaways
- Define whether the interaction is administrative messaging, asynchronous record review, a formal internet follow-up visit or an institution-to-institution consultation. These channels have different responsibilities.
- Remote review works best for a known diagnosis and planned question. New, rapidly changing or examination-dependent problems often require local in-person assessment.
- Use three named owners: the China team interprets its treatment, the local clinician examines and acts locally, and the patient or coordinator moves information between them.
- Every pending result needs sent–received–acknowledged–acted status. Posting a report in an app does not close the loop.
- End every encounter with a bilingual decision ledger: what was concluded, what remains uncertain, what changes now, who acts, by when, and what triggers urgent local care.
Content
A video call can bridge distance. It cannot palpate an abdomen, examine a wound in three dimensions, draw urgent blood, prescribe under every jurisdiction or transport a deteriorating patient.
Remote follow-up becomes reliable when its limits are designed into the workflow.
Name the service before using it
Four activities are often called “telemedicine”:
Mode · Typical purpose · Clinical boundary
administrative messaging · appointment, invoice, record or portal help · no diagnosis or treatment change
asynchronous review · clinician reviews uploaded reports/images and replies later · response time and urgent exclusions must be stated
scheduled internet follow-up · direct clinician–patient review of a known condition · eligibility, identity, consent and documentation required
institution-to-institution consultation · local clinician requests China specialist input · local institution remains essential for examination and action
China’s internet-diagnosis framework distinguishes direct internet follow-up from remote medical services between institutions and limits direct internet diagnosis to eligible follow-up contexts [1]. Do not send clinical questions to a marketing account and assume they entered the medical record.
Record the platform, institution, department, clinician, licence display route, fee, expected response time and whether a formal note or prescription will be generated.
Build the three-party loop
China treatment team
- explains the procedure, pathology, imaging, treatment delivery and intended surveillance;
- clarifies decisions made in China and reviews information within its remote-service scope;
- names the point at which local examination is required.
Local clinician
- examines the patient and obtains locally available tests;
- manages emergencies and conditions requiring physical care;
- interprets the plan within local standards, product availability and prescribing law;
- communicates findings back with patient consent.
Patient or coordinator
- maintains the current medication and event timeline;
- sends the right source documents through the approved channel;
- tracks owners and deadlines;
- escalates urgent symptoms locally instead of waiting online.
Write one name and backup for each role. “The hospital” and “my doctor at home” are not operational contacts.
Pass the remote-suitability screen
A remote appointment is more likely to be useful when:
- identity and prior treating relationship can be verified;
- the diagnosis and treatment episode are documented;
- the question is specific;
- required results and images can be shared in advance;
- the patient is clinically stable;
- a local examination route exists if the answer depends on physical findings.
China’s 2022 supervision rules require real-name use, relevant records with an established diagnosis and clinician assessment of follow-up eligibility. They require the clinician to stop the online encounter and direct the patient to in-person care when the condition changes, the case is effectively a first visit or remote care is unsuitable [2].
Do not use remote follow-up as a queue for severe breathing difficulty, chest pain, major bleeding, stroke signs, collapse, severe allergy, rapidly worsening infection or another emergency. Use local emergency services.
Submit a one-question interval packet
Send the packet early enough for review:
- one-sentence clinical question;
- treatment/procedure and date;
- interval-events timeline;
- current symptoms and functional change;
- reconciled medicines and recent changes;
- requested measurements, laboratories and reports;
- original DICOM or pathology source where relevant;
- photographs labelled with date, site and orientation when requested;
- local clinician’s examination and question;
- patient priorities for the decision.
Do not upload 300 unsorted files during the call. Use a manifest and mark preliminary, final and amended reports. State what is missing.
For imaging, include the report and original series rather than phone photographs of a screen. For a wound or movement video, obtain consent, remove unrelated people and avoid sending through a personal account not approved by the institution.
Prepare the encounter as a clinical appointment
Confirm:
- date and time in both time zones;
- patient passport/record identity;
- clinician identity and department;
- interpreter name and role;
- local clinician or caregiver attendance when needed;
- camera, sound, lighting and backup telephone;
- privacy on both sides;
- how consent and notes will be recorded.
Place medicines, device cards and the question list within reach. Do not drive or walk during a clinical video call. If an interpreter is used, speak in short segments and ask the patient to explain the final plan back.
Make examination limits visible
Separate observations into:
- patient-reported;
- visible on video;
- measured by a device;
- examined by a local clinician;
- not assessed.
Avoid turning poor video into a confident finding. Colour, swelling, tenderness, pulse, strength, sensation, abdominal signs and device function may require proper lighting, calibrated equipment or hands-on assessment.
If the China team needs local data, specify the question the examination or test should answer, not merely “do some labs.” The local clinician decides how to obtain and interpret it safely.
Close pending results as a state machine
Track each result through:
ordered/collected → final → sent → received → acknowledged → interpreted → action completed
AHRQ identifies result follow-up as a persistent diagnostic-safety problem and defines loop closure as results being sent, received, acknowledged and acted on [3]. A patient portal can support this process but cannot substitute for ownership.
For pathology, culture, molecular testing or final imaging that returns after departure, record:
- expected date;
- China reviewer;
- patient and local-clinician notification route;
- decision it may change;
- deadline for action;
- overdue backup contact.
If the result materially changes treatment, arrange a formal documented encounter rather than relying on an unexplained message.
Keep prescription and test authority honest
Before the call, clarify whether the China service can issue an online prescription in this encounter, whether it can be dispensed to the patient’s location and whether a home-country pharmacy or clinician can act on it. These are separate questions.
China’s internet-diagnosis supervision rules require prescriptions to be issued by the treating physician and regulate traceable prescription and medication workflows [2]. That does not make a Chinese electronic prescription automatically valid in another country.
Use the remote visit to explain the intended active ingredient, dose, monitoring and reason for change. A local authorised prescriber then decides how to implement it under local law and available products. The same applies to laboratory and imaging orders.
Use a decision ledger, not meeting minutes
Within 24 hours, create a short bilingual record:
Field · Required entry
conclusion · what the team believes now
evidence · reports, images or examination used
uncertainty · what cannot yet be decided remotely
action · medicine, test, wound/device or activity change
owner · named person or institution
deadline · actual date and time zone
escalation · symptom/result that requires earlier local care
next review · trigger or booked date
Ask the China team to correct factual errors and place the formal note in the appropriate record when the service supports it. Send the final ledger to the local clinician through the agreed channel.
Protect data across the border
Health information is sensitive. Use the institution’s approved platform, minimum necessary files, explicit recipient, purpose and retention plan. Avoid shared social accounts, public links and casual forwarding.
China’s Personal Information Protection Law contains rules for providing personal information outside China and requires measures to ensure the overseas recipient’s processing meets the law’s protection standard [4]. The exact responsibility depends on who is transferring and why; the hospital’s privacy/data office should advise on formal cross-border exchange.
The patient should also confirm whether the local provider may send examination, imaging or genetic information back to China, and how consent can be withdrawn. Preserve source files and an access log where practical.
Audit the loop monthly, then close it deliberately
For longer follow-up, maintain a compact dashboard:
- scheduled surveillance and due dates;
- completed and missed items;
- medication owner and next refill;
- pending results;
- current China and local contacts;
- unresolved decision;
- last emergency-plan review.
AHRQ notes that discharge summaries can omit pending tests and medicines, amplifying diagnostic risk across inpatient-to-outpatient transitions [5]. Do not assume the initial discharge document will carry the whole follow-up period.
End remote follow-up deliberately when the China team no longer adds clinical value, the local team has accepted full responsibility or a different service is needed. Give the patient a final summary, outstanding items, record-access route and conditions for re-contact. A dormant chat thread is not a care plan.
Medical disclaimer: This article provides general remote-follow-up planning information. Eligibility, licensure, prescribing, privacy and data-transfer rules depend on the institutions, clinicians, patient location and jurisdiction. New or severe symptoms require appropriate local in-person or emergency assessment.
FAQ
Is a WeChat message to the doctor a formal follow-up visit?
Not automatically. Confirm that the account belongs to the authorised institution or clinician, that the interaction is within an approved service, and whether it creates a documented medical record and defined response time.
Can a China doctor diagnose a new problem after I return home?
Remote eligibility is limited and new or changed problems may require local in-person evaluation. Under China’s internet-diagnosis rules, clinicians should terminate unsuitable online care and direct patients to a physical facility.
Can a Chinese online prescription be filled abroad?
Do not assume so. The China clinician can document the intended medicine and rationale, but a locally authorised prescriber and pharmacy must determine lawful implementation and product equivalence.
Who is responsible for a result that returns after departure?
Name the China reviewer, delivery route, local recipient, action deadline and overdue backup before leaving. The loop is complete only after the result is acknowledged, interpreted and acted on.
What if symptoms worsen while waiting for an online reply?
Use the local escalation plan. Severe or rapidly worsening symptoms should go to emergency or in-person care immediately; do not wait for a remote message or time-zone opening hours.
Sources
- National Health Commission of China — Internet Diagnosis, Internet Hospital and Remote Medical Service Framework
- National Health Commission of China — Internet Diagnosis and Treatment Supervision Rules
- Agency for Healthcare Research and Quality — Diagnostic Safety and Closing the Test-Result Loop
- Cyberspace Administration of China — Personal Information Protection Law
- Agency for Healthcare Research and Quality — Diagnostic Safety in Inpatient-to-Outpatient Transitions